Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04835012 · ClinicalTrials.gov registry record
Health and Health Care Utilization Effects of Medical Debt Forgiveness
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 15,008
- Enrollment target
NCT04835012: Completed study, sponsored by University of California, Los Angeles.
NCT04835012 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 15,008 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04835012 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 15,008 participants
- Enrollment target
Study Summary
The goal of this study is to estimate the direct, causal impact of medical debt on health care utilization, mental health, and wellbeing of patients. The investigators will conduct a survey to measure the impact of the debt forgiveness on health care use, mental health, and wellbeing. The survey will be administered to approximately 17,000 subjects of a recent medical financial intervention. In that prior intervention, a non-profit charity, RIP Medical Debt, purchased and abolished medical debt for a randomly selected about 6,000 (out of the 17,000) individuals. In this current protocol, the investigators will administer the survey, and will compare surveyed outcomes of subjects who received and did not receive the intervention.
Primary Outcome
Scores on the 8-item Patient Health Questionnaire depression scale range from 0 to 24, with higher scores indicating greater severity of depression.
Interventions
- OTHER Medical debt forgiveness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,008 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2021-12-31 |
What the finished NCT04835012 record still lists
NCT04835012 is an observational study that tracks outcomes without assigning an intervention. Its 15,008 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Medical debt forgiveness is the first listed.
NCT04835012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04835012 about?
NCT04835012 is a clinical study titled "Health and Health Care Utilization Effects of Medical Debt Forgiveness". The goal of this study is to estimate the direct, causal impact of medical debt on health care utilization, mental health, and wellbeing of patients. The investigators will conduct a survey to measure the impact of the debt forgiveness on health care use, mental health, and wellbeing. The survey wil...
What is the current status of trial NCT04835012?
This trial is currently completed. The enrollment target is 15,008 participants. The study started on 2020-11-09. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04835012?
The interventions under investigation include: Medical debt forgiveness (OTHER).
Who is sponsoring clinical trial NCT04835012?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI